Literature DB >> 27150289

Analgesic use - prevalence, biomonitoring and endocrine and reproductive effects.

David M Kristensen1, Séverine Mazaud-Guittot2, Pierre Gaudriault2, Laurianne Lesné2, Tania Serrano2,3, Katharina M Main4, Bernard Jégou2,3.   

Abstract

Paracetamol and NSAIDs, in particular acetylsalicylic acid (aspirin) and ibuprofen, are among the most used and environmentally released pharmaceutical drugs. The differences in international trends in the sale and consumption of mild analgesics reflect differences in marketing, governmental policies, habits, accessibility, disease patterns and the age distribution of each population. Biomonitoring indicates ubiquitous and high human exposure to paracetamol and to salicylic acid, which is the main metabolite of acetylsalicylic acid. Furthermore, evidence suggests that analgesics can have endocrine disruptive properties capable of altering animal and human reproductive function from fetal life to adulthood in both sexes. Medical and public awareness about these health concerns should be increased, particularly among pregnant women.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27150289     DOI: 10.1038/nrendo.2016.55

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  29 in total

1.  Use of Negative Control Exposure Analysis to Evaluate Confounding: An Example of Acetaminophen Exposure and Attention-Deficit/Hyperactivity Disorder in Nurses' Health Study II.

Authors:  Zeyan Liew; Marianthi-Anna Kioumourtzoglou; Andrea L Roberts; Éilis J O'Reilly; Alberto Ascherio; Marc G Weisskopf
Journal:  Am J Epidemiol       Date:  2019-04-01       Impact factor: 4.897

2.  Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe.

Authors:  Karima Hider-Mlynarz; Philippe Cavalié; Patrick Maison
Journal:  Br J Clin Pharmacol       Date:  2018-04-02       Impact factor: 4.335

Review 3.  Analgesic use in pregnancy and male reproductive development.

Authors:  Pablo Hurtado-Gonzalez; Rod T Mitchell
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-06       Impact factor: 3.243

Review 4.  Andrology: Ibuprofen and hypogonadism - bench to bedside to misinterpreted hype?

Authors:  Ajay K Nangia; Derek Jensen
Journal:  Nat Rev Urol       Date:  2018-03-06       Impact factor: 14.432

5.  Towards a Treatment for Gulf War Illness: A Consensus Docking Approach.

Authors:  Rajeev Jaundoo; Jonathan Bohmann; Gloria E Gutierrez; Nancy Klimas; Gordon Broderick; Travis J A Craddock
Journal:  Mil Med       Date:  2020-01-07       Impact factor: 1.437

Review 6.  Intrauterine Exposure to Acetaminophen and Adverse Developmental Outcomes: Epidemiological Findings and Methodological Issues.

Authors:  Zeyan Liew; Andreas Ernst
Journal:  Curr Environ Health Rep       Date:  2021-01-04

Review 7.  Azole Fungicides and Their Endocrine Disrupting Properties: Perspectives on Sex Hormone-Dependent Reproductive Development.

Authors:  Monica Kam Draskau; Terje Svingen
Journal:  Front Toxicol       Date:  2022-04-28

Review 8.  Environmental influences on ovarian dysgenesis - developmental windows sensitive to chemical exposures.

Authors:  Hanna Katarina Lilith Johansson; Terje Svingen; Paul A Fowler; Anne Marie Vinggaard; Julie Boberg
Journal:  Nat Rev Endocrinol       Date:  2017-04-28       Impact factor: 43.330

9.  Behavioral Problems at Age 11 Years After Prenatal and Postnatal Exposure to Acetaminophen: Parent-Reported and Self-Reported Outcomes.

Authors:  Kosuke Inoue; Beate Ritz; Andreas Ernst; Wan-Ling Tseng; Yuying Yuan; Qi Meng; Cecilia Høst Ramlau-Hansen; Katrine Strandberg-Larsen; Onyebuchi A Arah; Carsten Obel; Jiong Li; Jørn Olsen; Zeyan Liew
Journal:  Am J Epidemiol       Date:  2021-06-01       Impact factor: 4.897

Review 10.  REPRODUCTIVE TOXICOLOGY: Endocrine disruption and reproductive disorders: impacts on sexually dimorphic neuroendocrine pathways.

Authors:  Heather B Patisaul
Journal:  Reproduction       Date:  2021-10-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.